KMT2A and acute lymphoblastic leukemia: In particular, KMT2A-rearranged ALL types are characterized by hyperleukocytosis, a relatively high incidence of central nervous system (CNS) involvement, an aggressive course, and early relapses leading to a poor prognosis.